These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22052327)
1. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer. Blanco A; de la Hoya M; Balmaña J; Ramón y Cajal T; Teulé A; Miramar MD; Esteban E; Infante M; Benítez J; Torres A; Tejada MI; Brunet J; Graña B; Balbín M; Pérez-Segura P; Osorio A; Velasco EA; Chirivella I; Calvo MT; Feliubadaló L; Lasa A; Díez O; Carracedo A; Caldés T; Vega A Breast Cancer Res Treat; 2012 Feb; 132(1):307-15. PubMed ID: 22052327 [TBL] [Abstract][Full Text] [Related]
2. PALB2 analysis in BRCA2-like families. Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436 [TBL] [Abstract][Full Text] [Related]
4. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019 [TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of PALB2 gene in French breast cancer families. Damiola F; Schultz I; Barjhoux L; Sornin V; Dondon MG; Eon-Marchais S; Marcou M; ; Caron O; Gauthier-Villars M; de Pauw A; Luporsi E; Berthet P; Delnatte C; Bonadona V; Maugard C; Pujol P; Lasset C; Longy M; Bignon YJ; Fricker JP; Andrieu N; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Muller D Breast Cancer Res Treat; 2015 Dec; 154(3):463-71. PubMed ID: 26564480 [TBL] [Abstract][Full Text] [Related]
6. Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Gutiérrez-Enríquez S; de la Hoya M; Martínez-Bouzas C; Sanchez de Abajo A; Ramón y Cajal T; Llort G; Blanco I; Beristain E; Díaz-Rubio E; Alonso C; Tejada MI; Caldés T; Diez O Breast Cancer Res Treat; 2007 May; 103(1):103-7. PubMed ID: 17063271 [TBL] [Abstract][Full Text] [Related]
7. A novel PALB2 truncating mutation in an Italian family with male breast cancer. Vietri MT; Caliendo G; Casamassimi A; Cioffi M; De Paola ML; Napoli C; Molinari AM Oncol Rep; 2015 Mar; 33(3):1243-7. PubMed ID: 25529982 [TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. Delgado L; Fernández G; Grotiuz G; Cataldi S; González A; Lluveras N; Heguaburu M; Fresco R; Lens D; Sabini G; Muse IM Breast Cancer Res Treat; 2011 Jul; 128(1):211-8. PubMed ID: 21190077 [TBL] [Abstract][Full Text] [Related]
9. Germline PALB2 mutation analysis in breast-pancreas cancer families. Stadler ZK; Salo-Mullen E; Sabbaghian N; Simon JA; Zhang L; Olson SH; Kurtz R; Offit K; Foulkes WD; Robson ME; Tischkowitz M J Med Genet; 2011 Aug; 48(8):523-5. PubMed ID: 21415078 [TBL] [Abstract][Full Text] [Related]
10. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hellebrand H; Sutter C; Honisch E; Gross E; Wappenschmidt B; Schem C; Deissler H; Ditsch N; Gress V; Kiechle M; Bartram CR; Schmutzler RK; Niederacher D; Arnold N; Meindl A Hum Mutat; 2011 Jun; 32(6):E2176-88. PubMed ID: 21618343 [TBL] [Abstract][Full Text] [Related]
11. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930 [TBL] [Abstract][Full Text] [Related]
12. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family. Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P; Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer. Fernandes PH; Saam J; Peterson J; Hughes E; Kaldate R; Cummings S; Theisen A; Chen S; Trost J; Roa BB Cancer; 2014 Apr; 120(7):963-7. PubMed ID: 24415441 [TBL] [Abstract][Full Text] [Related]
14. PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations. Kim JH; Choi DH; Cho DY; Ahn SH; Son BH; Haffty BG Breast Cancer Res Treat; 2010 Jul; 122(1):303-6. PubMed ID: 20213081 [TBL] [Abstract][Full Text] [Related]
15. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases. Blanco A; de la Hoya M; Osorio A; Diez O; Miramar MD; Infante M; Martinez-Bouzas C; Torres A; Lasa A; Llort G; Brunet J; Graña B; Perez Segura P; Garcia MJ; Gutiérrez-Enríquez S; Carracedo Á; Tejada MI; Velasco EA; Calvo MT; Balmaña J; Benitez J; Caldés T; Vega A PLoS One; 2013; 8(7):e67538. PubMed ID: 23935836 [TBL] [Abstract][Full Text] [Related]
16. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473 [TBL] [Abstract][Full Text] [Related]
18. A recurrent mutation in PALB2 in Finnish cancer families. Erkko H; Xia B; Nikkilä J; Schleutker J; Syrjäkoski K; Mannermaa A; Kallioniemi A; Pylkäs K; Karppinen SM; Rapakko K; Miron A; Sheng Q; Li G; Mattila H; Bell DW; Haber DA; Grip M; Reiman M; Jukkola-Vuorinen A; Mustonen A; Kere J; Aaltonen LA; Kosma VM; Kataja V; Soini Y; Drapkin RI; Livingston DM; Winqvist R Nature; 2007 Mar; 446(7133):316-9. PubMed ID: 17287723 [TBL] [Abstract][Full Text] [Related]
19. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Ticha I; Kleibl Z; Stribrna J; Kotlas J; Zimovjanova M; Mateju M; Zikan M; Pohlreich P Breast Cancer Res Treat; 2010 Nov; 124(2):337-47. PubMed ID: 20135348 [TBL] [Abstract][Full Text] [Related]
20. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer. Downs B; Kim YC; Xiao F; Snyder C; Chen P; Fleissner EA; Becirovic D; Wen H; Sherman S; Cowan KH; Lynch HT; Wang SM Breast Cancer Res Treat; 2015 May; 151(1):219-24. PubMed ID: 25833210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]